We partner with pharmaceutical, biotechnology, and medical device companies—from emerging biotechs to global leaders—to deliver fully integrated solutions across early, preclinical, and clinical development. By combining scientific excellence with operational agility, we help accelerate timelines, de-risk development, and enable confident decision-making.

A key differentiator of our model is our own dedicated clinical research centre, allowing us to directly conduct and manage clinical studies with full control over quality, timelines, and patient operations. This integrated approach ensures seamless continuity from preclinical activities to clinical execution, while providing sponsors with greater flexibility, efficiency, and data consistency.

Our core capabilities span advanced therapeutics, bioanalytical and pharmacokinetic services, biomarkers and immunogenicity, clinical trial support, and data and bioinformatics. We also provide specialised expertise in topical product development, genomics and molecular testing, and veterinary drug development.

With this comprehensive, end-to-end portfolio—and the ability to perform clinical studies within our own clinical centre—we support the development of both small and large molecules at every stage, from early discovery through clinical phases, delivering robust, high-quality data that drives progress and maximises success.